Finding 479568 (2022-016)

Material Weakness Repeat Finding
Requirement
G
Questioned Costs
-
Year
2022
Accepted
2024-07-29

AI Summary

  • Core Issue: The organization lacks controls to ensure compliance with the 25% matching requirement for grant funds.
  • Impacted Requirements: All grant funds must be matched with at least 25% cash or in-kind contributions, tracked on a grant-by-grant basis.
  • Recommended Follow-Up: Management should develop formal controls to ensure compliance with matching requirements and prevent future issues.

Finding Text

Formerly 2021-002: Matching, Level of Effort, Earmarking: Federal Program: Assistance Listing Nos.: 14.267 Continuum of Care Program Condition: The organization was unable to demonstrate controls over the matching requirement. Criteria: The recipient or subrecipient must match all grant funds, except for leasing funds, with no less than 25 percent of cash or in-kind contributions from other sources. For CoC geographic areas in which there is more than one grant agreement, the 25 percent match must be provided on a grant-by-grant basis. Recipients that are a UFA or are the sole recipient for their Continuum may provide match on a Continuum-wide basis (24 CFR section 578.73(a)). Questioned Costs: There are no questioned costs. Effect: It is more likely that the Organizational will not meet the percent matching requirements since there is no formal set of controls over the requirement. Cause: The Organization did not have good controls on ensuring the matching requirement was met. Recommendation: In order to prevent future occurrences of this deficiency, we recommend that management develop a set of controls to ensure that they are meeting 25% match. Perspective: This is a systemic issue in that controls over the requirement have not been developed to ensure no issues arise. Repeat: This is a repeat finding. Responsible Official’s View: The Organization agrees with the finding. See attached corrective action plan.

Categories

Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 479551 2022-013
    Material Weakness
  • 479552 2022-013
    Material Weakness
  • 479553 2022-014
    Material Weakness Repeat
  • 479554 2022-014
    Material Weakness Repeat
  • 479555 2022-014
    Material Weakness Repeat
  • 479556 2022-014
    Material Weakness Repeat
  • 479557 2022-014
    Material Weakness Repeat
  • 479558 2022-014
    Material Weakness Repeat
  • 479559 2022-014
    Material Weakness Repeat
  • 479560 2022-014
    Material Weakness Repeat
  • 479561 2022-014
    Material Weakness Repeat
  • 479562 2022-015
    Material Weakness Repeat
  • 479563 2022-015
    Material Weakness Repeat
  • 479564 2022-015
    Material Weakness Repeat
  • 479565 2022-015
    Material Weakness Repeat
  • 479566 2022-016
    Material Weakness Repeat
  • 479567 2022-016
    Material Weakness Repeat
  • 479569 2022-016
    Material Weakness Repeat
  • 479570 2022-017
    Material Weakness Repeat
  • 479571 2022-017
    Material Weakness Repeat
  • 479572 2022-017
    Material Weakness Repeat
  • 479573 2022-017
    Material Weakness Repeat
  • 479574 2022-018
    Material Weakness Repeat
  • 479575 2022-018
    Material Weakness Repeat
  • 479576 2022-018
    Material Weakness Repeat
  • 479577 2022-018
    Material Weakness Repeat
  • 479578 2022-018
    Material Weakness Repeat
  • 479579 2022-018
    Material Weakness Repeat
  • 1055993 2022-013
    Material Weakness
  • 1055994 2022-013
    Material Weakness
  • 1055995 2022-014
    Material Weakness Repeat
  • 1055996 2022-014
    Material Weakness Repeat
  • 1055997 2022-014
    Material Weakness Repeat
  • 1055998 2022-014
    Material Weakness Repeat
  • 1055999 2022-014
    Material Weakness Repeat
  • 1056000 2022-014
    Material Weakness Repeat
  • 1056001 2022-014
    Material Weakness Repeat
  • 1056002 2022-014
    Material Weakness Repeat
  • 1056003 2022-014
    Material Weakness Repeat
  • 1056004 2022-015
    Material Weakness Repeat
  • 1056005 2022-015
    Material Weakness Repeat
  • 1056006 2022-015
    Material Weakness Repeat
  • 1056007 2022-015
    Material Weakness Repeat
  • 1056008 2022-016
    Material Weakness Repeat
  • 1056009 2022-016
    Material Weakness Repeat
  • 1056010 2022-016
    Material Weakness Repeat
  • 1056011 2022-016
    Material Weakness Repeat
  • 1056012 2022-017
    Material Weakness Repeat
  • 1056013 2022-017
    Material Weakness Repeat
  • 1056014 2022-017
    Material Weakness Repeat
  • 1056015 2022-017
    Material Weakness Repeat
  • 1056016 2022-018
    Material Weakness Repeat
  • 1056017 2022-018
    Material Weakness Repeat
  • 1056018 2022-018
    Material Weakness Repeat
  • 1056019 2022-018
    Material Weakness Repeat
  • 1056020 2022-018
    Material Weakness Repeat
  • 1056021 2022-018
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
16.576 Crime Victim Compensation $273,735
93.788 Opioid Str $85,216
14.267 Continuum of Care Program $60,141
93.558 Temporary Assistance for Needy Families $47,833
16.588 Violence Against Women Formula Grants $36,160
94.006 Americorps $23,030
10.558 Child and Adult Care Food Program $20,513